Determination of kininogens levels and kallikrein/kininase II activities in patients with thromboangiitis obliterans

Scandinavian Journal of Immunology

Volumn 72, Issue 2, 2010, Pages 128-133

  Dellalibera Joviliano, R ^a,b   Joviliano, E E ^b   Evora P R B ^b  

^a Integrated Faculty Fafibe   (Japan)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; HIGH MOLECULAR WEIGHT KININOGEN; KININ; LOW MOLECULAR WEIGHT KININOGEN; NICOTINE; PLASMA KALLIKREIN; TISSUE KALLIKREIN;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; BUERGER DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SALIVA LEVEL; SMOKING HABIT; VASCULAR CAPACITY; VASODILATATION;

ADULT; FEMALE; HUMANS; KININOGENS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PLASMA KALLIKREIN; SMOKING; STATISTICS, NONPARAMETRIC; THROMBOANGIITIS OBLITERANS; TISSUE KALLIKREINS;

EID: 77954390889     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02408.x     Document Type: Article

References (31)

1. Olin JW, Shih A. Thromboangiitis obliterans (Buerger's disease). Curr Opin Rheumatol 2006 18 : 18 24.
2. Chochola M, Márová K, Linhart A. Buerger's disease. Cas Lek Cesk 2006 145 : 358 362.
3. Lazarides MK, Georgiadis GS, Papas TT, Nikolopoulos ES. Diagnostic criteria and treatment of Buerger's disease: a review. Int J Low Extrem Wounds 2006 5 : 89 95.
4. Quintas A, Albuquerque R. Buerger's disease: current concepts. Rev Port Cir Cardiotorac Vasc 2008 15 : 31 8.
5. Tanaka K. Pathology and pathogenesis of Buerger's disease. Int J Cardiol 1998 1 : S237 42.
6. Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, Hiramori K. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger′s disease). Circulation 1996 9 (Suppl II211 5.
7. Cailleux N, Guegan-Massardier E, Borg JY et al. Pseudothromboangé ite oblitérante et déficit qualitatif en protéine C: a propos dún cas. J Mal Vasc 1996 21 : 47 9.
8. Doko S, Katsumura T, Fujiwara T, Inada H, Masaka H. Antiphospholipid antibody syndrome and vasoocclusive diseases. Int J Angiol 1995 4 : 55 60.
9. Stammler F, Diehm C, Hsu E, Stockinger K, Amendt K. The prevalence of hyperhomocysteinemia in thromboangiitis obliterans. Does homocysteine play a role pathogenetically. Dtsch Med Wochenschr 1996 121 : 1417 1423.
10. Maslowski L, McBane R, Alexewicz P, Wysokinski WE. Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med 2002 7 : 259 264.
11. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992 44 : 1 80.
12. Schmaier AH, Rojkaer R, Shariat-Madar Z. Activation of the plasma kallikrein/kinin system on cells: a revised hypothesis. Thromb Haemost 1999 82 : 226 233.
13. Colman RW. Biologic activities of the contact factors in vivo-potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Thromb Haemost 1999 82 : 1568 1577.
14. Margolius HS. Kallikreins and kinins. Molecular characteristics and cellular and tissue responses. Diabetes 1996 45 (Suppl 1 4 9.
15. Shionoya S. Diagnostic criteria of Buerger's disease. Int J Cardiol 1998 66 (Suppl 243 245.
16. Dellalibera-Joviliano R, Reis ML, Donadi EA. Kinin system in lupus nephritis. Int Immunopharmacol 2001 1 : 1889 1896.
17. Dellalibera-Joviliano R, Dos Reis ML, Cunha Fde Q, Donadi EA. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus. J Rheumatol 2003 30 : 485 492.
18. Diniz CR, Carvalho IF. A micromethod for determination of bradykininogen under several conditions. Ann N Y Acad Sci 1963 104 : 77 89.
19. Rothschild AM, Boden G, Colman RW. Kininogen changes in human plasma following a test meal or insulin administration. Am J Physiol 1996 270 : H1071 7.
20. Amundsen E, Putter M, Knos M, Claeson G. Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol 1979 120A : 83 95.
21. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971 20 : 1637 1648.
22. Scharfstein J, Schmitz V, Svensjö E, Granato A, Monteiro AC. Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation. Scand J Immunol 2007 66 : 128 136.
23. Ceconi C, Fox KM, Remme WJ et al. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 2007 73 : 237 246.
24. Eichhorn J, Sima D, Lindschau C et al. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998 315 : 17 23.
25. Little MA, Savage CO. The role of the endothelium in systemic small vessel vasculitis. Clin Exp Rheumatol 2008 26 (3 suppl 49 S135 40.
26. Hernández CC, Donadi EA, Reis ML. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome. J Rheumatol 1998 25 : 2381 2384.
27. Rosatelli TB, Roselino AM, Dellalibera-Joviliano R, Reis ML, Donadi EA. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem). Br J Dermatol 2005 152 : 650 657.
28. Ferreira SH, Lorenzetti BB, Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol 1993 110 : 1227 1231.
29. Kobayashi M, Nishikimi N, Komori K. Current pathological and clinical aspects of Buerger's disease in Japan. Ann Vasc Surg 2006 20 : 148 156.
30. Calixto JB, Cabrini DA, Ferreira J, Campos MM. Kinins in pain and inflammation. Pain 2000 87 : 1 5.
31. De La Cadena RA, Scott CF, Colman RW. Evaluation of a microassay for human plasma prekallikrein. J Lab Clin Med 1987 109 : 601 607.